SIRT1 and breast carcinoma: In this case, 50% (60 of 120) malignant tissues and 94% (30 of 32) metastases were nuclear SIRT1 negative/low (Fig. 7e), suggesting a reverse correlation between nuclear SIRT1 and breast cancer progression.